Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: VASCUMAB LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2016-11-15 to 2018-08-31
Current total value of award: $502312.06
Description: HDAC INHIBITORS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION, VITA 2